Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001193125-26-114576
Filing Date
2026-03-18
Accepted
2026-03-18 18:46:11
Documents
2
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 3315
2 EX-24 ck0001944885-ex24.htm EX-24 14872
  Complete submission text file 0001193125-26-114576.txt   19671
Mailing Address 989 EAST HILLSDALE BLVD. STE 220 FOSTER CITY CA 94404
Business Address 989 EAST HILLSDALE BLVD. STE 220 FOSTER CITY CA 94404 1-650-209-4055
Apollomics Inc. (Issuer) CIK: 0001944885 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 19 F., NO. 103, SEC. 1, RONGHUA RD. XINZHUANG DISTRICT NEW TAIPEI CITY Taiwan, Province of China 242045
Business Address
CHU YI-AN (Reporting) CIK: 0002115208 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41670 | Film No.: 26771291